Subcutaneous Abatacept in Renal Transplant Recipients

Condition:   Kidney Transplant Recipient Intervention:   Drug: Abatacept 125Mg/Ml Syringe Sponsors:   Idelberto Badell;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials